Refeyn
Generated by Meeveem AI
"Mass photometry pioneers measuring individual biomolecules with light"
Oxford
•51 - 250 Employees
•Biotechnology
About Refeyn
Refeyn develops mass photometry technology that measures individual biomolecules using light. The company's instruments analyse proteins, antibodies, viral vectors, and other molecules in their native state without labels. By detecting light scattering as molecules bind to a surface, mass photometry delivers rapid insights into purity, interactions, and structure using nanograms of material. Scientists and biopharmaceutical developers use Refeyn's platforms to accelerate discovery and quality control. The technology supports structural biology, gene therapy vector analysis, antibody development, and biotherapeutic manufacturing. Originating from the University of Oxford in 2018, Refeyn has installed over 500 instruments globally.
Illustrative visual - may not reflect the actual offering.
Illustrative visual - may not reflect the actual offering.
181
Team Members
2018
Founded
Series B
Funding
Hybrid
Work Environment
Our Vision
A world where every scientist has instant, accurate molecular insights to accelerate breakthrough discoveries and life saving therapies without the constraints of traditional analytical methods.
Our Mission
At Refeyn, our mission is to accelerate discovery through innovation, empowering scientific breakthroughs in basic research and transforming biotherapeutic development and manufacturing.